Xcout Intel
NewLimitUnicorn · $2–5B
NewLimit, Inc. is a for-profit company headquartered in South San Francisco, California, operating in the biotechnology or life sciences sector. The firm engages in ongoing research and scientific updates from its California headquarters.
Subscribe to see NewLimit’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NewLimit at a glance
NewLimit is a biotech company headquartered in United States. It has raised at least $682.2M across the 4 funding rounds on record. Its most recent funding round, Series C, raised $435M in July 2026. Xcout tracks 9 named people at NewLimit, including Jacob Kimmel (President). Xcout recorded 26 job postings from NewLimit in the last 90 days, naming tools such as Confluence, GitHub.
NewLimit leadership
- Jacob KimmelPresident
- Michael PolanskyPresident
- Jacob KimmelCEO and co-founder
- Blake Byersco-founder
- Brian Armstrongco-founder
- Jacob KimmelExecutive Officer
3 more named people on record for NewLimit, with roles, board committees and tenure — see the full roster →
NewLimit funding rounds
At least $682.2M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $435M | 7 named | |
| Series C | $45M | 13 named | |
| Series B | $130M | 11 named | |
| — | $72.2M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at NewLimit
Xcout recorded 26 job postings from NewLimit in the last 90 days, from a hiring record Xcout has kept since May 2026.
Tools named in NewLimit's job postings
The weekly hiring trend, the roles and locations behind it — see NewLimit's hiring signals →
Recent NewLimit news
Investors
Tech stack
NewLimit competitors
A few of NewLimit's closest competitors — see the full list of competitors and alternatives →
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Novome Biotechnologies, Inc. is a biotechnology company headquartered in South San Francisco, California. The company focuses on engineering defined activities into the human gut microbiota to develop novel treatments for chronic diseases.
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Ankasa Regenerative Therapeutics, Inc. is a for-profit biotechnology company headquartered in South San Francisco, California.
Marea Therapeutics is a biotechnology research company headquartered in South San Francisco, California. The company focuses on developing novel therapeutics within the biopharma sector.
Khloris Biosciences, Inc. is a life sciences company focused on therapeutic development with locations in California, including San Jose and South San Francisco.
Get NewLimit's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about NewLimit? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on NewLimit in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access